Skip to product information
1 of 4

Anthelios 100 KA+ MED

Anthelios 100 KA+ MED

Regular price Lek 2,775.00
Regular price Lek 3,700.00 Sale price Lek 2,775.00
-25% Rezervo
Tax included.
Size

La Roche Posay - Anthelios 100 KA+ MED Cream 50ml

NEW

FOR VERY PHOTOSENSITIVE SKIN
VERY HIGH PROTECTION. DOES NOT LEAVE WHITE MARKS.

WHAT IT IS

ANTHELIOS 100KA+MED is our first medical device to prevent Actinic Keratosis (AK) and non-melanoma skin cancer (NMSC) and reduce the carcinogenicity field in the epidermis as part of a wider treatment cycle.

APPLICATION For topical
use only. Apply before sun exposure or immediately after treatment. To ensure optimal protection, the following amounts (2mg/cm2) should be applied:
Apply the product every morning to the skin of the head, face, neck, décolleté and hands and reapply when needed for complete protection from sunlight. Sufficient quantity per application for complete protection: scalp: 5 pressures, face: 5 presses, neck: 3 presses, décolleté: 7 presses, hands:
8 presses.
If applied to all of the above areas, use the product a maximum of 5 times a day.

TEXTURE

Cream. It does not leave white marks. It does not cause flaws.

KEY BENEFITS

Very high broad spectrum protection against UVA & UVB. Promotes the protection of the epidermal barrier. It promotes the repair of DNA damage by blocking UV radiation.

THE SCIENCE BEHIND THE PRODUCT

Very high broad spectrum protection against UVA & UVB thanks to a patented, photostable filter system including Mexoryl®. It provides protection against the development of cancerous (except melanoma) and precancerous actinic lesions, as well as DNA damage caused by the sun, in patients with very photosensitive skin at risk of actinic hyperkeratosis (phototypes I-II) or undergoing immunosuppressive therapy. Moisturizing composition, with DNA RESTORATION TECHNOLOGY, enriched with NIACINAMIDE and PANTHENOL
Dermatologically tested. Tested for allergies.

La Roche-Posay is the #1 skin care brand recommended by dermatologists worldwide* *

Source: Research conducted in the dermocosmetics market, conducted by AplusA and other partners during the period January 2021-July 2021, involving dermatologists in 34 countries, representing over 82% of global GDP

 

Expiry date after opening the package:
12 months
View full details